AU2002300268B2 - New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
AU2002300268B2
AU2002300268B2 AU2002300268A AU2002300268A AU2002300268B2 AU 2002300268 B2 AU2002300268 B2 AU 2002300268B2 AU 2002300268 A AU2002300268 A AU 2002300268A AU 2002300268 A AU2002300268 A AU 2002300268A AU 2002300268 B2 AU2002300268 B2 AU 2002300268B2
Authority
AU
Australia
Prior art keywords
formula
compounds
branched
linear
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002300268A
Other languages
English (en)
Other versions
AU2002300268A1 (en
Inventor
John Hickman
Michel Koch
Sylvie Michel
Abdelhakim El Omri
Bruno Pfeiffer
Alain Pierre
Pierre Renard
Elisabeth Seguin
Francois Tillequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of AU2002300268A1 publication Critical patent/AU2002300268A1/en
Application granted granted Critical
Publication of AU2002300268B2 publication Critical patent/AU2002300268B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2002300268A 2001-07-25 2002-07-25 New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them Ceased AU2002300268B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01.09910 2001-07-25
FR0109910A FR2827864B1 (fr) 2001-07-25 2001-07-25 Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
AU2002300268A1 AU2002300268A1 (en) 2003-06-12
AU2002300268B2 true AU2002300268B2 (en) 2008-05-22

Family

ID=8865868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300268A Ceased AU2002300268B2 (en) 2001-07-25 2002-07-25 New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US6642248B2 (enExample)
EP (1) EP1297835B1 (enExample)
JP (1) JP2003055381A (enExample)
KR (1) KR100498868B1 (enExample)
CN (1) CN1231484C (enExample)
AR (1) AR036346A1 (enExample)
AT (1) ATE373478T1 (enExample)
AU (1) AU2002300268B2 (enExample)
BR (1) BR0202864A (enExample)
CA (1) CA2395652C (enExample)
DE (1) DE60222515T2 (enExample)
DK (1) DK1297835T3 (enExample)
EA (1) EA005374B1 (enExample)
ES (1) ES2294090T3 (enExample)
FR (1) FR2827864B1 (enExample)
HK (1) HK1053646B (enExample)
HU (1) HUP0202485A3 (enExample)
MX (1) MXPA02006914A (enExample)
NO (1) NO20023556L (enExample)
NZ (1) NZ520377A (enExample)
PL (1) PL355188A1 (enExample)
PT (1) PT1297835E (enExample)
SI (1) SI1297835T1 (enExample)
ZA (1) ZA200205961B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856687B1 (fr) * 2003-06-25 2005-09-16 Servier Lab Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865734B1 (fr) * 2004-02-03 2006-05-19 Servier Lab NOUVAEUX DERIVES DE BENZO[b]CHROMENO-NAPHTHYRIDIN-7-ONE ET DE PYRANO[2'3':7,8]QUINO[2,3-b]QUINOXALIN-7-ONE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
FR2879600B1 (fr) * 2004-12-22 2007-02-09 Servier Lab Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN107068881B (zh) * 2016-04-25 2019-12-03 中节能万润股份有限公司 一种含有吖啶酮类化合物的有机电致发光器件及其应用
CN115594592B (zh) * 2021-06-28 2024-03-19 江西天宇化工有限公司 一种2-氯-3-硝基苯甲酸的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224169D0 (en) * 1992-11-18 1993-01-06 Lilly Industries Ltd Pharmaceutical compounds
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
FR2772765B1 (fr) * 1997-12-19 2000-03-17 Adir Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PL355188A1 (en) 2003-01-27
NO20023556D0 (no) 2002-07-25
EA200200712A1 (ru) 2003-02-27
JP2003055381A (ja) 2003-02-26
FR2827864A1 (fr) 2003-01-31
CN1398863A (zh) 2003-02-26
EA005374B1 (ru) 2005-02-24
US6642248B2 (en) 2003-11-04
FR2827864B1 (fr) 2005-09-16
US20030073841A1 (en) 2003-04-17
HK1053646B (zh) 2006-04-21
NZ520377A (en) 2004-03-26
CA2395652A1 (fr) 2003-01-25
KR100498868B1 (ko) 2005-07-04
ZA200205961B (en) 2003-04-01
KR20030010513A (ko) 2003-02-05
BR0202864A (pt) 2003-06-03
HUP0202485A2 (hu) 2003-04-28
ATE373478T1 (de) 2007-10-15
ES2294090T3 (es) 2008-04-01
MXPA02006914A (es) 2005-07-25
EP1297835B1 (fr) 2007-09-19
HU0202485D0 (enExample) 2002-09-28
EP1297835A1 (fr) 2003-04-02
CA2395652C (fr) 2008-12-30
PT1297835E (pt) 2007-10-19
DE60222515T2 (de) 2008-07-03
DK1297835T3 (da) 2008-01-28
NO20023556L (no) 2003-01-27
AR036346A1 (es) 2004-09-01
DE60222515D1 (de) 2007-10-31
HK1053646A1 (en) 2003-10-31
CN1231484C (zh) 2005-12-14
SI1297835T1 (sl) 2007-12-31
HUP0202485A3 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
CA2067491A1 (en) Camptothecin analogs as potent inhibitors of human colorectal cancer
KR100301093B1 (ko) 인돌유도체,그제조방법및그의약용도
US5364858A (en) Camptothecin analogs as potent inhibitors of topoisomerase I
US6268375B1 (en) 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
AU2002300268B2 (en) New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
AU760863B2 (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
US7056929B2 (en) Benzo[b]pyrano[3,2-h]acridin-7-one compounds
JP3364473B2 (ja) ７−オキソ−２，３，７，１４−テトラヒドロ−１Ｈ−ベンゾ〔ｂ〕ピラノ〔３，２−ｈ〕アクリジンカルボキシラートの新しい化合物、これらの製造方法及びこれらを含む医薬組成物
JP4308156B2 (ja) 新規なベンゾ［ｂ］クロメノ−ナフチリジン−７−オン及びピラノ［２′，３′：７，８］キノ［２，３−ｂ］キノキサリン−７−オン化合物、それらの製法並びにそれらを含む医薬組成物
US20040266753A1 (en) Benzo[a]pyrano[3,2-h]acridin-7-one compounds
ZA200510323B (en) Benzo[B]pyrano[3,2-H]acridin-2-one cinnamate compounds, a process for their preparation and pharmaceutical compositions containing them
GB2280674A (en) Pyrido[3,4-b]-pyridine antitumor compounds

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired